These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8422287)

  • 1. Suramin-induced growth inhibition and insulin-like growth factor-I binding blockade in human breast carcinoma cell lines: potentially related events.
    Ravera F; Miglietta L; Pirani P; Ferrini S; Favoni RE
    Eur J Cancer; 1993; 29A(2):225-30. PubMed ID: 8422287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.
    Minniti CP; Maggi M; Helman LJ
    Cancer Res; 1992 Apr; 52(7):1830-5. PubMed ID: 1312901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suramin interferes with auto/paracrine insulin-like growth factor I-controlled proliferative loop on human lung cancer cell lines.
    Favoni RE; Ravera F; Pirani P; Ardizzoni A; Noonan D; de Cupis A
    Eur J Pharmacol; 1994 Oct; 264(2):199-206. PubMed ID: 7851483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of insulin like growth factor II autocrine growth of Wilms' tumor by suramin in vitro and in vivo.
    Vincent TS; Hazen-Martin DJ; Garvin AJ
    Cancer Lett; 1996 May; 103(1):49-56. PubMed ID: 8616808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.
    Favoni RE; de Cupis A; Bruno S; Yee D; Ferrera A; Pirani P; Costa A; Decensi A
    Br J Cancer; 1998 Jun; 77(12):2138-47. PubMed ID: 9649125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells.
    Pollak M; Richard M
    J Natl Cancer Inst; 1990 Aug; 82(16):1349-52. PubMed ID: 2166171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of suramin on 125I-insulin-like growth factor-I binding to human meningiomas and on proliferation of meningioma cells.
    Tsutsumi K; Kitagawa N; Niwa M; Himeno A; Taniyama K; Shibata S
    J Neurosurg; 1994 Mar; 80(3):502-9. PubMed ID: 8113863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth.
    Baghdiguian S; Verrier B; Gerard C; Fantini J
    Cancer Lett; 1992 Feb; 62(1):23-33. PubMed ID: 1311629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of breast cancer growth by suramin.
    Vignon F; Prebois C; Rochefort H
    J Natl Cancer Inst; 1992 Jan; 84(1):38-42. PubMed ID: 1738172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro.
    Foekens JA; Sieuwerts AM; Stuurman-Smeets EM; Dorssers LC; Berns EM; Klijn JG
    Int J Cancer; 1992 May; 51(3):439-44. PubMed ID: 1592534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.
    Lawrence JB; Conover CA; Haddad TC; Ingle JN; Reid JM; Ames MM; Suman VJ; Marks RS; Erlichman C; Hartmann LC
    Clin Cancer Res; 1997 Oct; 3(10):1713-20. PubMed ID: 9815555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
    Arteaga CL; Osborne CK
    Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
    Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
    J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suramin and serum insulin-like growth factor levels in metastatic cancer patients.
    Miglietta L; Barreca A; Repetto L; Costantini M; Rosso R; Boccardo F
    Anticancer Res; 1993; 13(6B):2473-6. PubMed ID: 8135485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells.
    Xia Y; Jin L; Zhang B; Xue H; Li Q; Xu Y
    Life Sci; 2007 May; 80(23):2161-2169. PubMed ID: 17499312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates herceptin activity in vivo.
    Jerome L; Alami N; Belanger S; Page V; Yu Q; Paterson J; Shiry L; Pegram M; Leyland-Jones B
    Cancer Res; 2006 Jul; 66(14):7245-52. PubMed ID: 16849573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
    Ricort JM; Binoux M
    Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative.
    Chakravarti B; Siddiqui JA; Dwivedi SK; Deshpande S; Samanta K; Bhatta RS; Panda G; Prabhakar YS; Konwar R; Sanyal S; Chattopadhyay N
    Mol Cell Endocrinol; 2011 May; 338(1-2):68-78. PubMed ID: 21457754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells.
    Steller MA; Delgado CH; Zou Z
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):11970-4. PubMed ID: 8618825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.